UBS’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$144K Sell
3,902
-8,494
-69% -$307K ﹤0.01% 5541
2014
Q2
$484K Sell
12,396
-85,416
-87% -$3.17M ﹤0.01% 4253
2014
Q1
$3.69M Buy
97,812
+23,160
+31% +$809K ﹤0.01% 2162
2013
Q4
$2.82M Buy
74,652
+69,008
+1,223% +$2.64M ﹤0.01% 2463
2013
Q3
$245K Sell
5,644
-40,878
-88% -$1.64M ﹤0.01% 4931
2013
Q2
$1.68M Buy
+46,522
New +$1.41M ﹤0.01% 2734

Other funds holding USNA

UBS's USNA Position: Q3 2014 in Review

UBS reduced its Usana Health Sciences (USNA) stake by 69% in Q3 2014, selling an estimated $307K and leaving 3,902 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #5541.

UBS first reported a position in USNA in Q2 2013 and has held it in 6 quarters since. The position peaked at $3.69M in Q1 2014. 124 funds tracked by Wall St. Rank hold USNA as of Q3 2014.

  • UBS held 3,902 shares of Usana Health Sciences worth $144K as of Q3 2014.
  • UBS sold 8,494 Usana Health Sciences shares in Q3 2014, an estimated $307K.
  • Usana Health Sciences made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5541 holding.
  • UBS first reported a position in Usana Health Sciences in Q2 2013 and has held it in 6 quarters since.
  • UBS's Usana Health Sciences position peaked at $3.69M in Q1 2014.
  • 124 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.